About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Molecule Plays a Dual Role in Autoimmune Uveitis

by Samhita Vitta on July 24, 2020 at 11:30 AM
Font : A-A+

Molecule Plays a Dual Role in Autoimmune Uveitis

Interleukin-17A (IL-17A) is an inflammatory molecule. It triggers immune cells which in turn reduce IL-17A's pro-inflammatory activity, according to a study by National Eye Institute(NEI) researchers.

In models of autoimmune diseases of the eye and brain, blocking IL-17A increased the presence of other inflammatory molecules produced by Th17 cells, immune cells that produce IL-17A and are involved in neuroinflammation. The finding could explain why IL-17-targeted treatments for conditions like the eye disease autoimmune uveitis and multiple sclerosis (MS) have failed. A report on the findings was published in Immunity. NEI is a part of the National Institutes of Health.

Advertisement


In autoimmune uveitis, immune cells become abnormally activated and begin to destroy healthy cells, including light-sensing photoreceptors and neurons. A key immune cell involved in this response is the Th17 lymphocyte, which produces several pro-inflammatory molecules known as cytokines.

A hallmark of Th17 cells is the ability to produce IL-17A, which attracts immune cells called neutrophils that can damage tissue. Nevertheless, multiple clinical trials of drugs that block IL-17A have failed to help people with autoimmune uveitis or MS.
Advertisement

"IL-17 is the prototypical inflammatory immune molecule blamed for autoimmunity in the neuro-retina and the brain, but there's been some controversy about the role it plays," said Rachel Caspi, Ph.D., chief of the Laboratory of Immunology at NEI and senior author of the study. "In our model of autoimmune uveitis, we noticed that without IL-17, the amount of tissue damage unexpectedly stayed the same and we had higher levels of other inflammatory molecules."

Caspi and colleagues used mouse models to investigate how IL-17A functions in the course of disease. The researchers were able to selectively remove IL-17A from Th17 cells and examine the cells' behavior in models of both uveitis and MS.

Curiously, they found that these cells produce more IL-17F, GM-CSF, and possibly other inflammatory molecules. The researchers concluded that these additional inflammatory cytokines compensate for the loss of IL-17A in driving inflammation.

"How could this work? we asked ourselves," said Caspi. "Scientists are like little kids, when they get an answer to one question, there is immediately the next level of 'why?' So we started looking at the deeper mechanisms that make the whole thing tick."

Usually, the IL-17A signal is picked up by other cells - including retinal tissue cells and neutrophils - that carry the IL-17 receptor. This receptor is a cell-surface protein cells that fits with IL-17A like a lock and key. But in this case, the researchers found copies of the IL-17 receptor on the surface of the Th17 cells that made the IL-17A in the first place.

"The process of cells binding a signal they have themselves produced - called autocrine signaling - has been known to happen in other cell types on occasion. But it hasn't been seen in Th17 cells before," said Caspi.

Caspi and colleagues found that when IL-17A binds to its receptor on Th17 cells, this triggers a signaling cascade that turns up the cells' production of an anti-inflammatory molecule, interleukin-24 (IL-24), which was not previously known to be produced by Th17 cells. IL-24 in turn suppresses the rest of the Th17 cells' inflammatory program, turning down the production of cytokines like IL-17F, GM-CSF and possibly IL-22.

Thus, without IL-17A, this autocrine loop does not happen, causing the Th17 cells to overproduce the other inflammatory cytokines and thereby increase inflammation.

IL-17A has been associated with several types of uveitis, a disease that causes up to 15% of cases of blindness in the U.S. Uveitis is generally treated with steroids, which can have serious side-effects.

"There are some diseases, like psoriasis, where anti-IL-17A therapy has been spectacularly successful. We expected that this would also apply to uveitis, but it turned out not the be the case," said Caspi. "This study might explain why clinical trials targeting IL-17A to treat uveitis were not successful, and suggests that a combination approach involving both IL-17A and IL-24 may be more effective in treating autoimmune disorders of the nervous system."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
First-Ever Successful Pig-To-Human Kidney Transplantation
World Osteoporosis Day 2021 -
Spirituality and Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Ankylosing Spondylitis Amyotrophic Lateral Sclerosis (ALS) Myasthenia Gravis Vitiligo Autoimmune Disorders Granulomatosis with Polyangiitis (GPA) Microscopic Polyangiitis Uveitis Acute Coronary Syndrome 

Recommended Reading
Autoimmune Disorders
Autoimmune disorders occur when the immune system fails to recognize the body as 'self' and attacks ...
Treatment That Preserves Long-Term Vision In Patients With Uveitis
Oral corticosteroids and immunosuppression may be a preferable initial choice for therapy of the ......
Multiple Sclerosis (MS) Does Not Worsen Following Pregnancy
Childbirth may not increase the risk of relapse of multiple sclerosis (MS). Women can safely ......
Gut Microbes Could Treat Autoimmune Disorder
The microorganisms found in the gut were found to alleviate symptoms of autoimmune disorder IPEX ......
Acute Coronary Syndrome
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic red...
Amyotrophic Lateral Sclerosis (ALS)
Find out more about the degenerative disease- Amyotrophic lateral sclerosis....
Ankylosing Spondylitis
Ankylosing spondylitis is a rheumatic disease that causes arthritis of the spine and sacro iliac ......
Granulomatosis with Polyangiitis (GPA)
Granulomatosis with Polyangiitis (GPA) is a type of vasculitis that usually affects the upper airway...
Microscopic Polyangiitis
Microscopic polyangitis, infection of small blood vessels, presents with general symptoms of fever, ...
Myasthenia Gravis
Myasthenia gravis is the commonest disorder of neuromuscular transmission. Autoimmune myasthenia gra...
Uveitis
Uveitis refers to inflammation of the uvea of the eye resulting in swelling and destruction of eye t...
Vitiligo
Vitiligo is a skin disease characterized by patches of unpigmented skin. Vitiligo is usually slowly ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use